PURDUE PHARMA LP

CA

Pharmaceutical manufacturer

Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 5 of its records are shown together here.

Filings
178
Filed By
5
Reported In-House
$12,659,826
Reported By Firms
$3,139,000

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2017 PURDUE PHARMA, LP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$170,000
2017 CAPITOL HILL CONSULTING GROUP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$50,000
2017 PURDUE PHARMA, LP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$200,000
2017 CAPITOL HILL CONSULTING GROUP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$50,000
2017 CAPITOL HILL CONSULTING GROUP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$50,000
2017 PURDUE PHARMA, LP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$390,000
2017 DENTONS US LLP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Termination (No Activity)
—
2017 PURDUE PHARMA, LP 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$180,000
2017 CAPITOL HILL CONSULTING GROUP 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$50,000
2017 DENTONS US LLP 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report (No Activity)
—
Filed By
FirmFilingsAmount
PURDUE PHARMA, LP 81 $12,659,826
CAPITOL HILL CONSULTING GROUP 78 $3,039,000
MCKENNA, LONG & ALDRIDGE 8 $40,000
KING & SPALDING LLP 2 $40,000
DENTONS US LLP 9 $20,000
Issue Areas

Bills Mentioned in Filings